UK Biobank Study on Metabolic-Inflammation Indices and Systemic Lupus Erythematosus Risk

UK Biobank data from 398,200 participants was used to evaluate the association of metabolic and inflammation vulnerability indices with incident systemic lupus erythematosus. The study, authored by Dongqi Zhou, followed participants for a median of 13.2 years and found significant associations between the indices and SLE risk. The dataset was last updated on May 8, 2026.

Use Cases

• Assessing the association between the metabolic vulnerability index (MVX) and SLE incidence based on the reported hazard ratios.
• Investigating non-linear dose-response relationships between inflammation vulnerability index (IVX) and disease risk using restricted cubic spline analysis.
• Performing subgroup analyses by demographics and lifestyle factors to identify effect modifiers for SLE risk.
• Validating the robustness of findings using sensitivity analyses like landmark analysis and competing risk models.

Strengths

• Data is derived from a large cohort of 398,200 UK Biobank participants.
• Study includes a long median follow-up period of 13.2 years.
• Analysis employs multiple statistical methods, including Cox models and Fine-Gray competing risk models.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The primary data file is a 37.6 KB DOCX document, suggesting limited raw data scope.

Provenance

Source

UK Biobank

Collection Method

Prospective cohort study using health records and biomarker data.

Time Range

Median follow-up of 13.2 years (specific start/end dates not provided).

Freshness

Last updated 2026-05-08 05:56:51; freshness should be verified.

Geography

United Kingdom